ISSN: 0803-7051

Journal Home

Journal Guideline

Blood Pressure Q2 Unclaimed

Informa Healthcare United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Blood Pressure is a journal indexed in SJR in Medicine (miscellaneous) and Internal Medicine with an H index of 56. It has a price of 2395 €. It has an SJR impact factor of 0,486 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,486.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Internal Medicine (Q2) Cardiology and Cardiovascular Medicine (Q3) Medicine (miscellaneous) (Q3)

Price

2395 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,486

SJR Impact factor

56

H Index

47

Total Docs (Last Year)

146

Total Docs (3 years)

1483

Total Refs

224

Total Cites (3 years)

121

Citable Docs (3 years)

1.55

Cites/Doc (2 years)

31.55

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical Rheumatology Q2
Pharmacological Reports Q2
Journal of Human Nutrition and Dietetics Q2
Diseases of the Colon and Rectum Q2
Oncology Reports Q2

Compare this journals

Aims and Scope

Best articles by citations

Myocardial Insulin-mediated Glucose Uptake and Left Ventricular Geometry

Role of Ambulatory Blood Pressure Monitoring in the Assessment and Prognosis of Patients with Borderline Hypertension

Cardiovascular consequences and management of high-normal blood pressure -more work needs to be done

Interactions of the Renin-angiotensin System and Alpha-1 Adrenoceptors on Renal Hemodynamics in Healthy and Acute Renal Failure Rats: The Role of Nitric Oxide

Genetic Factors in Hypertension -What is Known and What Does It Mean?

Beta-Adrenergic Blocking Drugs in the Treatment of Hypertension

More Non-Q-wave Myocardial Infarctions but Similar Infarct Sizes in Patients with Hypertension

Pharmacology of AT 1 -receptor Blockers

Diabetes and Hypertension

AT 1 -receptor Blocker-based Combination Therapy in Hypertension

Antihypertensive Effects of Valsartan/Hydrochlorothiazide Combination in Essential Hypertension

Home Blood Pressure Monitoring. Current Knowledge and Directions for Future Research

SHOW MORE ARTICLES

The Captopril Prevention Project, Further Analyses on Left Ventricular Hypertrophy and Diabetes

Inhibiting Renin-Angiotensin in the Brain: the Possible Therapeutic Implications

Evaluation of Endothelium-Dependent Vasodilation in Humans

ESH Scientific Newsletter

Calcium Antagonists in Hypertension

Renal Participation in Cardiovascular Risk in Essential Hypertension

Familial Obesity, Sympathetic Activation and Blood Pressure Level

Effects of Omapatrilat on Blood Pressure and Insulin Sensitivity in an Animal Model of Insulin Resistance

Hypertension treatment and stroke prevention

Prevalence of Left Ventricular Hypertrophy and Carotid Thickening in a Large Selected Hypertensive Population: Impact of Different Echocardiographic and Ultrasonographic Diagnostic Criteria

Long-term Renal and Cardiovascular Effects of Antihypertensive Treatment Regimens based upon Isradipine, Perindopril and Thiazide